| 16.05 00:48 | dpa-AFX: GNW-Adhoc: ONWARD® Medical plant Webcast zur Vorstellung des Geschäftsverlaufs im 1. Quartal 2024 |
| 16.05 00:48 | GNW-Adhoc: ONWARD® Medical plant Webcast zur Vorstellung des Geschäftsverlaufs im 1. Quartal 2024 |
| 16.05 00:43 | dpa-AFX: GNW-Adhoc: ONWARD® Medical plant Webcast zur Vorstellung des Geschäftsverlaufs im 1. Quartal 2024 |
| 15.05 00:21 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update |
| 02.05 07:00 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions |
| 25.04 07:30 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date |
| 09.04 07:00 | dpa-AFX: GNW-Adhoc: Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00 |
| 02.04 07:30 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System |
| 25.03 17:40 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France |
| 21.03 18:26 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Publishes Prospectus for Listing of New Shares |
| 21.03 03:03 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Successfully Raises ?20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France |
| 20.03 18:29 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option |
| 20.03 18:24 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option |
| 18.03 07:30 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® System |
| 15.03 07:35 | dpa-AFX: GNW-Adhoc: ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing |
| 15.03 07:35 | GNW-Adhoc: ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing |
| 15.03 07:30 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights |
| 15.03 07:30 | dpa-AFX: GNW-Adhoc: ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing |
| 11.03 07:30 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCIT System |
| 29.02 07:41 | dpa-AFX: GNW-Adhoc: ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA |
|
|
